Texas 2025 - 89th Regular

Texas House Bill HB4783

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Impact

If enacted, HB4783 will establish a structured approach for state agencies to report on the effectiveness and reach of opioid antagonist distribution programs. This includes not only statistics on current supplies but also recommendations for future improvements, particularly targeting vulnerable populations such as school-aged children and pregnant women. By focusing on statewide saturation goals and establishing strategic partnerships with various state agencies and institutions, the bill seeks to create a comprehensive framework addressing opioid overdoses.

Summary

House Bill 4783 aims to enhance the state of Texas' response to the opioid crisis by mandating a biennial report on governmental programs concerning opioid antagonists, which are critical in reversing and preventing opioid overdoses. The bill requires the Health and Safety Commission to evaluate the distribution of these antagonists and assess the needs of the current opioid antagonist program. This initiative represents recognition of the severity of opioid overdoses and the need for systematic intervention strategies across the state.

Contention

While the bill is expected to garner broad support due to its focus on public health, concerns may arise regarding the adequacy of resources dedicated to these programs and how effectively they can respond to the nuances of opioid addiction in different communities. There may also be discussions on the implications of state versus local control in health programs, especially in areas dealing with unique challenges related to opioid use. Stakeholders will likely debate the best methods for executing the bill's provisions efficiently while ensuring comprehensive coverage and effective outcomes.

Texas Constitutional Statutes Affected

Health And Safety Code

  • Chapter 461a. Department Of State Health Services: Chemical Dependency Services And Related Programs
    • Section: New Section

Companion Bills

TX SB2378

Similar Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

TX HB4058

Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.

MT SB503

Allow use of expired opioid antagonists

TX HB3338

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

TX HB1103

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

TX SB556

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

IL HB3326

METRA-NALOXONE REQUIREMENT